Title : Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Pub. Date : 2018 Nov 29

PMID : 30345906






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: Atezolizumab plus nab-paclitaxel prolonged progression-free survival among patients with metastatic triple-negative breast cancer in both the intention-to-treat population and the PD-L1-positive subgroup. nab CD274 molecule Homo sapiens